Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation (Editorial)
File version
Author(s)
O'Gorman, N
Roberge, S
Bujold, E
Hyett, J
Uzan, S
Beaufils, M
Costa, F da Silva
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Despite the wealth of research on screening for and prevention of pre-eclampsia (PE) published in the last three decades, this condition remains one of the main causes of maternal and perinatal morbidity and mortality, both in low- and high-income countries. It affects 2–8% of all pregnancies, being responsible for one out of five maternal deaths and 15% of all preterm deliveries.
Journal Title
Ultrasound in Obstetrics & Gynecology
Conference Title
Book Title
Edition
Volume
50
Issue
5
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Reproductive medicine
Science & Technology
Life Sciences & Biomedicine
Acoustics
Obstetrics & Gynecology
Persistent link to this record
Citation
Rolnik, DL; O'Gorman, N; Roberge, S; Bujold, E; Hyett, J; Uzan, S; Beaufils, M; Costa, FDS, Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation (Editorial), Ultrasound in Obstetrics & Gynecology, 2017, 50 (5), pp. 551-556